Long-term tricuspid valve prosthesis-related complications in patients with congenital heart disease

Slooten, Ymkje J. van; Freling, Hendrik G.; Melle, Joost P. van; Mulder, Barbara J.M.; Jongbloed, Monique R.M.; Ebels, Tjark; Voors, Adriaan A.; Pieper, Petronella G.

doi:10.1093/ejcts/ezt259

Cited by 28 publications

(27 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4 Then, these valves need to be replaced again. 5 Since the advent of percutaneous valve implantation in the year 2000, 6 many patients have been treated successfully with a percutaneously implanted valve in the aortic or pulmonic position. The failing bioprosthesis usually is an ideal landing zone for a percutaneously implanted valve, if the dimensions are well defined and valve size is adequate.…”

mentioning

confidence: 99%

Percutaneous Tricuspid Valve Implantation

Eicken

Schubert

Hager

et al. 2015

Circ: Cardiovascular Interventions

View full text Add to dashboard Cite

Background-Severe tricuspid valve (TV) dysfunction may lead to surgical TV replacement with a biological valve prosthesis in patients with congenital heart disease. To expand the lifetime of this valve and reduce the number of surgeries, percutaneous TV implantation (PTVI) may be an effective alternative to repeated surgery. We report on our 2-center experience with PTVI. Methods and Results-Between 2008 and 2014, 17 percutaneous valves were implanted in 16 patients with TV bioprosthesis dysfunction (9 females) from 2 centers. Median age and weight were 31.3 years (5-77.2) and 65.2 kg (17.7-107); 14 patients had congenital heart disease (univentricular heart with a right atrial to right ventricle bioprosthesis in 3, Ebstein's anomaly of the TV in 5, and other in 6), and 2 had acquired TV dysfunction. All procedures were successful (Melody n=7, Sapien 26 mm valve n=4, Sapien XT 29 mm valve n=6). One valve showed early dysfunction. It was replaced surgically and shortly after that a repeated PTVI was performed. The median duration of follow-up was 2.1 years (3 days to 6.3 years). The percutaneous valve was performing well in 15 of 16 patients. Conclusions-PTVI was safe and effectively improved TV function in all but 1 patient at midterm follow-up. We think that PTVI is a good alternative to repeated surgical TV replacements and that it may reduce the total number of open heart surgeries in these patients. (Circ Cardiovasc Interv. 2015;8:e002155.

show abstract

mentioning

confidence: 99%

Percutaneous Tricuspid Valve Implantation

Eicken

Schubert

Hager

et al. 2015

Circ: Cardiovascular Interventions

View full text Add to dashboard Cite

show abstract

“…PSI is a cooperation of all eight Dutch University Medical Centers (UMCs) and aims at building large prospectively collected datasets with uniform and standardized storage of biomaterials for complex diseases. Currently, PSI covers 18 disease-specific cohorts called 'Pearls', and this number is still growing [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18]. PSI is centrally organized and has an executive board for operational management to ensure collective standardization strategies.…”

Section: Project Descriptionmentioning

confidence: 99%

“…Regarding all disease cohorts, the research projects based on PSI data and samples have led to several scientific publications [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16]18].…”

Section: Release Datementioning

confidence: 99%

Dutch Parelsnoer Institute-Cerebrovascular Accident (CVA) Study: A Large Multicenter Clinical Biobank with Standardized Collection and Storage

Ruigrok

Manniën³

et al. 2018

Open Journal of Bioresources

View full text Add to dashboard Cite

“…In 2007, the Netherlands Federation of University Medical Centers (NFU) launched the Parelsnoer Institute (PSI) [1], with the aim of facilitating medical research and innovation ultimately leading to better diagnosis, treatment or even prevention of complex disorders [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17]. PSI is a collaborative network of all eight Dutch University Medical Centers (UMCs), also known as academic teaching hospitals.…”

Section: Project Descriptionmentioning

confidence: 99%

“…PSI releases data and samples to research projects on a regular basis. Thus far, the research projects have led to many scientific publications [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17].…”

Section: Release Datementioning

confidence: 99%

The Parelsnoer Institute: A National Network of Standardized Clinical Biobanks in the Netherlands

Manniën

Ledderhof²,

Verspaget

et al. 2017

Open Journal of Bioresources

View full text Add to dashboard Cite

The Parelsnoer Institute (PSI) is a collaborative biobanking project of all eight University Medical Centers in the Netherlands which was launched in 2007. Basically, PSI consists of three dimensions: participating institutions, disease entities and a central organization. An executive board for operational management instigates collective strategic and tactic policies and a central team of PSI experts and advisors supports the researchers and the board in establishing and implementing standards and procedures. PSI offers researchers an infrastructure and standard procedures for the establishment, expansion and optimisation of clinical biobanks for scientific research. To ensure patient privacy clinical data is pseudomized and carefully stored in a central database. Human biomaterials are collected according to nationally agreed standards.Currently PSI covers fifteen large disease specific cohorts (the so-called 'Parels' or 'Pearls') and new 'Pearls' are being developed. The Parelsnoer Institute currently (December 2016) has stored more than 538,000 biospecimens with annotated clinical data of more than 30,000 patients. All these materials and data are available for anyone with a bona fide research proposal.

show abstract

Long-term tricuspid valve prosthesis-related complications in patients with congenital heart disease

Abstract: Compared with previous literature on acquired valvar disease, we found a higher incidence of valve-related complications in patients with congenital heart disease that was unrelated to prosthesis material. Our data suggest that PPM may have a negative effect on the event-free interval.

Cited by 28 publications

References 22 publications

Percutaneous Tricuspid Valve Implantation

Percutaneous Tricuspid Valve Implantation

Dutch Parelsnoer Institute-Cerebrovascular Accident (CVA) Study: A Large Multicenter Clinical Biobank with Standardized Collection and Storage

The Parelsnoer Institute: A National Network of Standardized Clinical Biobanks in the Netherlands

Contact Info

Product

Resources

About